Coagulation changes during packed red cell replacement of major blood loss

D. J. Murray, John D Olson, R. Strauss, J. H. Tinker

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

A greater proportion of blood replacement needs are being met by packed red cell concentrates rather than whole blood in situations of major blood loss. Twelve patients, who required major blood replacement during elective surgery, were studied to determine the changes in coagulation when packed red cells were used to replace major blood loss. In addition, the coagulation abnormalities present at the time a observer noted excessive bleeding were determined. Prior to blood product replacement and after the estimated loss of each 0.3 blood volume, coagulation tests were obtained including prothrombin time (PT), partial thromboplastin time (aPTT), platelet count, thrombin time (TT), fibrinogen levels, and assays of coagulation Factors V, VIII, and IX. Coagulation tests were repeated when clinical hemostasis was judged inadequate by the anesthesiologist and attending surgeon. Significant decreases in platelet count, fibrinogen levels, and Factor V, VIII, and IX levels occurred as increasing blood volumes were replaced. Increases in PT and aPTT above control occurred in nine of the 12 patients prior to replacement of 1 blood volume; none of the nine patients had increased clinical bleeding. In four of seven patients who had blood replacement of greater than 1 blood volume, increased clinical bleeding was noted by the observer. Platelet counts were less than 100,000/mm3 in each of those four patients, and a platelet concentrate obtained by pheresis of a single donor was administered. In two of the four patients platelet counts increased, but clinical bleeding did not resolve. Fresh-frozen plasma (FFP) in addition to the platelet concentrate was used in these two patients. In both patients fibrinogen levels were less than 75 mg/dl, and the PT and aPTT were 1.5 times control values prior to FFP. If prolongation of PT and PTT had been used as the indication for administration of FFP, nine of the 12 patients would have unnecessarily received FFP prior to the loss of 1 blood volume. In situations when packed red cells are used for major blood replacement, clotting factors in the form of FFP may not be necessary to maintain the PT or PTT at accepted normal levels.

Original languageEnglish (US)
Pages (from-to)839-845
Number of pages7
JournalAnesthesiology
Volume69
Issue number6
StatePublished - 1988
Externally publishedYes

Fingerprint

Prothrombin Time
Blood Volume
Platelet Count
Fibrinogen
Hemorrhage
Factor IX
Factor V
Factor VIII
Blood Coagulation Tests
Blood Platelets
Thrombin Time
Blood Component Removal
Blood Coagulation Factors
Partial Thromboplastin Time
Blood Coagulation
Hemostasis
Tissue Donors

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Murray, D. J., Olson, J. D., Strauss, R., & Tinker, J. H. (1988). Coagulation changes during packed red cell replacement of major blood loss. Anesthesiology, 69(6), 839-845.

Coagulation changes during packed red cell replacement of major blood loss. / Murray, D. J.; Olson, John D; Strauss, R.; Tinker, J. H.

In: Anesthesiology, Vol. 69, No. 6, 1988, p. 839-845.

Research output: Contribution to journalArticle

Murray, DJ, Olson, JD, Strauss, R & Tinker, JH 1988, 'Coagulation changes during packed red cell replacement of major blood loss', Anesthesiology, vol. 69, no. 6, pp. 839-845.
Murray DJ, Olson JD, Strauss R, Tinker JH. Coagulation changes during packed red cell replacement of major blood loss. Anesthesiology. 1988;69(6):839-845.
Murray, D. J. ; Olson, John D ; Strauss, R. ; Tinker, J. H. / Coagulation changes during packed red cell replacement of major blood loss. In: Anesthesiology. 1988 ; Vol. 69, No. 6. pp. 839-845.
@article{562bde46da1849508e9c6ab941cd1620,
title = "Coagulation changes during packed red cell replacement of major blood loss",
abstract = "A greater proportion of blood replacement needs are being met by packed red cell concentrates rather than whole blood in situations of major blood loss. Twelve patients, who required major blood replacement during elective surgery, were studied to determine the changes in coagulation when packed red cells were used to replace major blood loss. In addition, the coagulation abnormalities present at the time a observer noted excessive bleeding were determined. Prior to blood product replacement and after the estimated loss of each 0.3 blood volume, coagulation tests were obtained including prothrombin time (PT), partial thromboplastin time (aPTT), platelet count, thrombin time (TT), fibrinogen levels, and assays of coagulation Factors V, VIII, and IX. Coagulation tests were repeated when clinical hemostasis was judged inadequate by the anesthesiologist and attending surgeon. Significant decreases in platelet count, fibrinogen levels, and Factor V, VIII, and IX levels occurred as increasing blood volumes were replaced. Increases in PT and aPTT above control occurred in nine of the 12 patients prior to replacement of 1 blood volume; none of the nine patients had increased clinical bleeding. In four of seven patients who had blood replacement of greater than 1 blood volume, increased clinical bleeding was noted by the observer. Platelet counts were less than 100,000/mm3 in each of those four patients, and a platelet concentrate obtained by pheresis of a single donor was administered. In two of the four patients platelet counts increased, but clinical bleeding did not resolve. Fresh-frozen plasma (FFP) in addition to the platelet concentrate was used in these two patients. In both patients fibrinogen levels were less than 75 mg/dl, and the PT and aPTT were 1.5 times control values prior to FFP. If prolongation of PT and PTT had been used as the indication for administration of FFP, nine of the 12 patients would have unnecessarily received FFP prior to the loss of 1 blood volume. In situations when packed red cells are used for major blood replacement, clotting factors in the form of FFP may not be necessary to maintain the PT or PTT at accepted normal levels.",
author = "Murray, {D. J.} and Olson, {John D} and R. Strauss and Tinker, {J. H.}",
year = "1988",
language = "English (US)",
volume = "69",
pages = "839--845",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Coagulation changes during packed red cell replacement of major blood loss

AU - Murray, D. J.

AU - Olson, John D

AU - Strauss, R.

AU - Tinker, J. H.

PY - 1988

Y1 - 1988

N2 - A greater proportion of blood replacement needs are being met by packed red cell concentrates rather than whole blood in situations of major blood loss. Twelve patients, who required major blood replacement during elective surgery, were studied to determine the changes in coagulation when packed red cells were used to replace major blood loss. In addition, the coagulation abnormalities present at the time a observer noted excessive bleeding were determined. Prior to blood product replacement and after the estimated loss of each 0.3 blood volume, coagulation tests were obtained including prothrombin time (PT), partial thromboplastin time (aPTT), platelet count, thrombin time (TT), fibrinogen levels, and assays of coagulation Factors V, VIII, and IX. Coagulation tests were repeated when clinical hemostasis was judged inadequate by the anesthesiologist and attending surgeon. Significant decreases in platelet count, fibrinogen levels, and Factor V, VIII, and IX levels occurred as increasing blood volumes were replaced. Increases in PT and aPTT above control occurred in nine of the 12 patients prior to replacement of 1 blood volume; none of the nine patients had increased clinical bleeding. In four of seven patients who had blood replacement of greater than 1 blood volume, increased clinical bleeding was noted by the observer. Platelet counts were less than 100,000/mm3 in each of those four patients, and a platelet concentrate obtained by pheresis of a single donor was administered. In two of the four patients platelet counts increased, but clinical bleeding did not resolve. Fresh-frozen plasma (FFP) in addition to the platelet concentrate was used in these two patients. In both patients fibrinogen levels were less than 75 mg/dl, and the PT and aPTT were 1.5 times control values prior to FFP. If prolongation of PT and PTT had been used as the indication for administration of FFP, nine of the 12 patients would have unnecessarily received FFP prior to the loss of 1 blood volume. In situations when packed red cells are used for major blood replacement, clotting factors in the form of FFP may not be necessary to maintain the PT or PTT at accepted normal levels.

AB - A greater proportion of blood replacement needs are being met by packed red cell concentrates rather than whole blood in situations of major blood loss. Twelve patients, who required major blood replacement during elective surgery, were studied to determine the changes in coagulation when packed red cells were used to replace major blood loss. In addition, the coagulation abnormalities present at the time a observer noted excessive bleeding were determined. Prior to blood product replacement and after the estimated loss of each 0.3 blood volume, coagulation tests were obtained including prothrombin time (PT), partial thromboplastin time (aPTT), platelet count, thrombin time (TT), fibrinogen levels, and assays of coagulation Factors V, VIII, and IX. Coagulation tests were repeated when clinical hemostasis was judged inadequate by the anesthesiologist and attending surgeon. Significant decreases in platelet count, fibrinogen levels, and Factor V, VIII, and IX levels occurred as increasing blood volumes were replaced. Increases in PT and aPTT above control occurred in nine of the 12 patients prior to replacement of 1 blood volume; none of the nine patients had increased clinical bleeding. In four of seven patients who had blood replacement of greater than 1 blood volume, increased clinical bleeding was noted by the observer. Platelet counts were less than 100,000/mm3 in each of those four patients, and a platelet concentrate obtained by pheresis of a single donor was administered. In two of the four patients platelet counts increased, but clinical bleeding did not resolve. Fresh-frozen plasma (FFP) in addition to the platelet concentrate was used in these two patients. In both patients fibrinogen levels were less than 75 mg/dl, and the PT and aPTT were 1.5 times control values prior to FFP. If prolongation of PT and PTT had been used as the indication for administration of FFP, nine of the 12 patients would have unnecessarily received FFP prior to the loss of 1 blood volume. In situations when packed red cells are used for major blood replacement, clotting factors in the form of FFP may not be necessary to maintain the PT or PTT at accepted normal levels.

UR - http://www.scopus.com/inward/record.url?scp=0024246902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024246902&partnerID=8YFLogxK

M3 - Article

VL - 69

SP - 839

EP - 845

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 6

ER -